Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats
MARMARA MEDICAL JOURNAL, vol.32, no.1, pp.27-32, 2019 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 32 Issue: 1
- Publication Date: 2019
- Doi Number: 10.5472/marumj.518821
- Journal Name: MARMARA MEDICAL JOURNAL
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.27-32
- Keywords: Algan hemostatic agent, Hemostasis, Rat, Bleeding control, Splenectomy, MEDICINAL-PLANT EXTRACT, ANKAFERD BLOOD STOPPER, N-ACETYL GLUCOSAMINE, FIBRIN SEALANT, POSTOPERATIVE ADHESIONS, ACHIEVING HEMOSTASIS, SPLENIC INJURY, SWINE MODEL, EFFICACY, MANAGEMENT
- Recep Tayyip Erdoğan University Affiliated: Yes
Abstract
Objective: Algan hemostatic agent (AHA) is a plant-based hemostatic agent produced in Turkey. Although, there is a great improvement in the hemostatic technologies, more effective hemostatic products are required to be produced. The aim of this study was to demonstrate the efficacy of AHA in a partial splenectomy model in rats. In addition, in this model, postoperative abdominal adhesion was evaluated.